2020

  • Stegherr R, Allignol A, Meister R, Schaefer C, Beyersmann J. Estimating cumulative incidence functions in competing risks data with dependent left-truncation. Stat Med. 2020;39(4):481-93

  • Philipps W, Fietz A-K, Meixner K, Bluhmki T, Meister R, Schaefer C, Padberg S. Pregnancy outcome after first‑trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort study. Infection. 2020;48(1):57-64

  • Kayser A, Beck E, Hoeltzenbein M, Zinke S, Meister R, Weber-Schoendorfer C, Schaefer C. Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups. Journal of Hypertension. 2020;38(2):354-61

2019

  • Dathe K, Frank J, Padberg S, Hultzsch S, Meixner K, Beck E, Meister R, Schaefer C. Negligible risk of prenatal ductus arteriosus closure or fetal renal impairment after thirdtrimester paracetamol use: evaluation of the German Embryotox cohort. BJOG. 2019

  • Bluhmki T, Fietz A-K, Stegherr R, Beck E, Padberg S, Beyersmann J, Schaefer C, Meister R. Multistate methodology improves risk assessment under time - varying drug intake - a new view on pregnancy outcomes following coumarin exposure. Pharmacoepidemiology and Drug Safety. 2019

  • Hoeltzenbein M, Tissen-Diabaté T, Fietz A-K, Schäfer M, Kayser A, Weber-Schoendorfer C, Beck E, Meister R, Schaefer C. Challenges in analysis of antihypertensive exposures and birth defect rates in women with chronic hypertension: an evaluation of the German Embryotox Database [Abstract]. Med Genetik. 2019;31(1):142

2018

  • Hoeltzenbein M, Fietz A-K, Kayser A, Zinke S, Meister R, Weber-Schoendorfer C, Schaefer C. Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study. J Hypertens. 2018:1.

  • Hoeltzenbein M, Tissen-Diabaté T, Fietz A-K, Zinke S, Kayser A, Meister R, Weber-Schoendorfer C, Schaefer C. Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors – Treatment or hypertension related? An observational cohort study. Pregnancy Hypertension. 2018;13:65-71.

  • Dathe K, Fietz AK, Pritchard LW, Padberg S, Hultzsch S, Meixner K, Meister R, Schaefer C. No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort. Reprod Toxicol. 2018;79:32-8.

  • Padberg S, Tissen-Diabate T, Dathe K, Hultzsch S, Meixner K, Linsenmeier V, Meister R, Schaefer C. Safety of diclofenac use during early pregnancy: A prospective observational cohort study. Reprod Toxicol. 2018;77:122-9.

  • Dathe K, Padberg S, Hultzsch S, Kohler LM, Meixner K, Fietz AK, Tissen-Diabate T, Meister R, Schaefer C. Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study. Eur J Clin Pharmacol. 2018;74(4):489-95.

  • Hoeltzenbein M, Tissen-Diabate T, Fietz AK, Zinke S, Kayser A, Meister R, Weber-Schoendorfer C, Schaefer C. Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study. Clinical research in cardiology : official journal of the German Cardiac Society. 2018:1-9.

2017

  • Dathe K, Padberg S, Hultzsch S, Köhler LM, Meixner K, Fietz AK, Tissen-Diabaté T, Meister R, Schaefer C. Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study. Eur J Clin Pharmacol. 2017 Dec 7. doi:10.1007/s00228-017-2385-1. [Epub ahead of print] PubMed PMID: 29214381.

  • Dathe K, Padberg S, Hultzsch S, Meixner K, Tissen-Diabaté T, Meister R, Beck E, Schaefer C. Metamizole use during first trimester-A prospective observational cohort study on pregnancy outcome. Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1197-1204. doi: 10.1002/pds.4277. Epub 2017 Aug 3. PubMed PMID: 28771890.

  • Spielmann K, Kayser A, Beck E, Meister R, Schaefer C. Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study. Cephalalgia.017 Jan 1:333102417724152. doi: 10.1177/0333102417724152. [Epub ahead of print] PubMed PMID: 28758416.

  • Hoeltzenbein M, Beck E, Fietz AK, Wernicke J, Zinke S, Kayser A, Padberg S, Weber-Schoendorfer C, Meister R, Schaefer C. Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study. Hypertension. 2017 Jul;70(1):201-208. doi: 10.1161/HYPERTENSIONAHA.117.09110. Epub 2017 May 22. PubMed PMID: 28533329.

  • Hüttel E, Padberg S, Meister R, Beck E, Schaefer C. Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment. Thromb Haemost. 2017 May 3;117(5):870-879. doi: 10.1160/TH16-11-0838. Epub 2017 Feb 23. PubMed PMID: 28229160.

  • Elger W, Wyrwa R, Ahmed G, Meece F, Nair HB, Santhamma B, Killeen Z, Schneider B, Meister R, Schubert H, Nickisch K. Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):305-311. doi:10.1016/j.jsbmb.2016.07.008. Epub 2016 Jul 20. PubMed PMID: 27449818.

2015

  • Wacker E, Navarro A, Meister R, Padberg S, Weber-Schoendorfer C, Schaefer C. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome. Pharmacoepidemiol Drug Saf 2015; 24: 353-60.
  • Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N; network of French pharmacovigilance centres, Beghin D, Cuppers-Maarschalkerweerd B, Richardson JL, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Kadioglu Duman M, Meister R, Schaefer C. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol 2015 Mar 25. DOI: 10.1111/bcp.12642.

2014

  • Nickisch K, Elger W, Santhamma B, Garfield R, Killeen Z, Amelkina O, Schneider B, Meister R. Synthesis and biological evaluation of 11' imidazolyl antiprogestins and mesoprogestins. Steroids. 2014 Dec 15;92:45-55. doi: 10.1016/j.steroids.2014.08.017. Epub 2014 Aug 28. PubMed PMID: 25174783.
  • Padberg S, Wacker E, Meister R, Panse M, Weber-Schoendorfer C, Oppermann M, Schaefer C. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones. Antimicrob Agents Chemother. 2014 Aug;58(8):4392-8. doi: 10.1128/AAC.02413-14. Epub 2014 May 19. PubMed PMID: 24841264; PubMed Central PMCID: PMC4136025.
  • Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N; Network of French Pharmacovigilance Centers, Shechtman S, Johnson D, Cuppers-Maarschalkerweerd B, Pistelli A, Clementi M, Winterfeld U, Eleftheriou G, Pupco A, Kao K, Malm H, Elefant E, Koren G, Vial T, Ornoy A, Meister R, Schaefer  C. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol. 2014 May;66(5):1101-10. doi: 10.1002/art.38368. PubMed PMID: 24470106.
  • Tümmler G, Rißmann A, Meister R, Schaefer C. Congenital bladder exstrophy associated with Duogynon hormonal pregnancy tests-signal for teratogenicity or consumer report bias? Reprod Toxicol. 2014 Jun;45:14-9. doi: 10.1016/j.reprotox.2013.12.007. Epub 2014 Jan 2. PubMed PMID: 24389232.
  • Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study. Rheumatology (Oxford). 2014 Apr;53(4):757-63. doi: 10.1093/rheumatology/ket390. Epub 2013 Dec 24. PubMed PMID: 24369411.

2013

  • Habermann F, Fritzsche J, Fuhlbrück F, Wacker E, Allignol A, Weber-Schoendorfer C, Meister R, Schaefer C. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013 Aug;33(4):453-62. doi: 10.1097/JCP.0b013e318295fe12. PubMed PMID: 23764684.

2012

  • Hoeltzenbein M, Weber-Schoendorfer C, Borisch C, Allignol A, Meister R, Schaefer C. Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine. Reprod Toxicol. 2012 Nov;34(3):364-9. doi: 10.1016/j.reprotox.2012.05.001. Epub 2012 May 16. PubMed PMID: 22609326.
  • Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, Schaefer C. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012 Jun 22;30(30):4445-52. doi: 10.1016/j.vaccine.2012.04.081. Epub 2012 May 5. PubMed PMID: 22564554.

2009

  • Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet. 2010 Feb; 281(2): 221-7. Epub 2009 May 15. Schaefer C, Meister R, Weber-Schoendorfer C. (2009)
  • Fetal outcome after technetium scintigraphy in early pregnancy. Reprod Toxicol. 2009 Sep; 28(2): 161-6. Epub 2009 May 13. Schaefer C, Meister R, Wentzeck R, Weber-Schoendorfer C. (2009)

2008

  • Statistical methods for estimating the probability of spontaneous abortion in observational studies - analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol. 2008 Sep; 26(1): 31-5. Epub 2008 Jun 26. Meister R, Schaefer C. (2008)
  • Using observational cohort data for studying drug effects on pregnancy outcome - methodological considerations. Reprod Toxicol. 2008 Sep; 26(1): 36-41. Epub 2008 Jun 7. Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. (2008)
  • The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol. 2008 Sep; 26(1): 24-30. Epub 2008 Jun 7. Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C. (2008)
  • GlobalANCOVA: exploration and assessment of gene group effects. Bioinformatics. 2008 Jan 1; 24(1): 78-85. Epub 2007 Nov 17. Hummel M, Meister R, Mansmann U. (2008)
  • Pregnancy outcome after exposure to calcium channel blockers during the first trimester. A prospective multicentre observational study. Reprod Toxicol 2008 . Available online DOI information: 10.1016/j.reprotox.2008.05.065. Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers- Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert- Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C. (2008)
  • Environmental Hazard Classi cation of Metals and Metal Compounds - A Probabilistic Assessment of Classi cation Power for Data Generated by the T/D Protocol. TemaNord 2008: 518. Nordic Council of Ministers, Copenhagen 2008 ISBN 978-92-893-1663-7. Meister R, Falck J. (2008)

2007

  • Global testing of differential gene expression.Vignette R-package GlobalAncova Version 3.0. URL: www.bioconductor.org. Hummel M, Meister R, Mansmann U. (2007)
  • GlobalAncova with Special Sum of Squares Decompositions. Vignette R-package GlobalAncova Version 3.0. URL: www.bioconductor.org. Scheufele R, Hummel M, Meister R, Mansmann U. (2007)
  • GlobalANCOVA: Exploration and Assessment of Gene Group E ects. Bioinformatics. doi: 10.1093/bioinformatics/btm531. Hummel M, Meister R, Mansmann U. (2007)

2006

  • Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006 Jun; 95(6): 949-57. Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P. (2006)
  • Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. Int J Cancer. 2006 Oct 15; 119(8): 1829-36. Erratum in: Int J Cancer. 2007 Jul 15; 121(2): 466. Groene J, Mansmann U, Meister R, Staub E, Roepcke S, Heinze M, Klaman I, Brümmendorf T, Hermann K, Loddenkemper C, Pilarsky C, Mann B, Adams HP, Buhr HJ, Rosenthal A.
  • GobalAncova: A Global test for dfferential gene expression. R-package Version 2.2.0. URL: www.bioconductor.org. Mansmann U, Meister R, Hummel M. (2006)
  • Global testing of differential gene expression Version 2.2.0. Vignette www.bioconductor.org. Mansmann U, Meister R, Hummel M. (2006)

2005

  • Testing differential gene expression in functional groups: Goeman's global test versus an ANCOVA approach. Methods of Information in Medicine. Mansmann U, Meister R. (2005)
  • Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS. Reprod Toxicol. 2005 Sep-Oct; 20(3): 331-43. Review. Schaefer C, Hannemann D, Meister R. (2005)
  • Overall test for differential expression in functionally related sets of genes. Abstract, 51. Biometrisches Kolloquium in Halle (Saale). Meister R, Mansmann U. (2005)
  • Microarray Daten bei klinischen Studien. Klassifikation und Validierung. In: Statistische Methoden in der empirischem Forschung. ISSN 1439-6696. Meister R. (2005)
  • GobalAncova: A Global test for differential gene expression. R-package URL: www.bioconductor.org. Meister R, Mansmann U. (2005)
  • Global testing of differential gene expression. Vignette www.bioconductor.org. Meister R, Mansmann U, Hummel M. (2005)

2004

  • GobalAncova: A Global test for differential gene expression. R-package URL: www.biometrie.uni-heidelberg.de/mb/SASmakros.htm. Meister R, Mansmann U. (2004)Differenzenmatrix - Ein Kriterium zur Charakterisierung der Präzision bewertender Prüfungen mit Qualtitätszahl in der Sensorik. Fleischwirtschaft 11, 125-128. Hildebrand G, Bergmann R, Bracher-Schöll K, Meister R. (2004)

2003

  • Wirtschaftsmathematik / Statistik. (Online Modul: Virtuelle Fachhochschule) vfh.tfh-berlin.de, www.vfh.de, www.oncampus.de. Meister R, Tschepki V. (2003)

2000

  • Toxikologische Risiken für Mensch und Umwelt - Statistische Verfahren bei der Bewertung von Chemikalien. In: Statistische Methoden in der empirischem Forschung. ISSN 1439-6696. Meister R (TFH Berlin), Weiß H (FU Berlin) eds. 120-129. Meister R. (2000)
  • Methods for Laboratory Experiments. In: Statistics in Ecotoxicology. Sparks, T. ed. Wiley. 99-118. Meister R, Van den Brink P. (2000)
  • Session Summary (Data Analysis and Reduction). In: Progress in The Reduction, Refinement and Replacement of Animal Experimentation. Balls M, Zeller AM Halder ME eds. Elsevier, Amsterdam 749-750. Meister R. (2000)
  • Improving data analysis: new aspects in toxicity testing using time-to-event data. In: Progress in The Reduction, Refinement and Replacement of Animal Experimentation. Balls M, Zeller AM, Halder ME eds. Elsevier, Amsterdam 759-772. Meister R. (2000)

1998

  • Vergleichende statistische Analysen der Forschungsinventarien der EU und der US EPA zu hormonell wirksamen Umweltchemikalien. TFH Berlin und F. & E. Berichte, Umweltbundesamt Berlin. Meister R, Bauerfeind A, Huscher D, Kobetic S. (1998)

1996

  • Risikoabschätzung bei quantitativen Dosis-Wirkungskurven mit SAS-Beispielen. Manuskript, 22 Seiten. Meister R. (1996)
  • Zur quantitativen Risikobewertung von Stoffen -- Chancen für Alternativmethoden? in: Forschung ohne Tierversuche, Ed.: Schöffel H, Spielmann H, Tritthart HA, Kußler K, Götsch, AS, Gruber, FP, Reinhart Ch; Springer, Wien, New York. Meister R. (1996)
  • Benchmarks for Quantitative Endpoints: An Approach Accounting for Litter Effects. Communications in Statistics (12/96). Schuster C, Meister R. (1996)

1995

  • Biostatistische Methoden für die Risikoabschätzung ökotoxischer Stoffe. Schriftenreihe der AG Ökologie der Deutschen Region der Internationalen Biometrischen Gesellschaft. Meister R. (1995)
  • Embryotoxicity Induced by Alkylating Agents: 9. Low Dose Prenatal-Toxic Risk Estimation of Ethylmethanesulfonate Based on No-Observed-Adverse-Effect Risk Factor Approach, Dose-Response Relationships, and Molecular Dosimetry. Teratogenesis, Carcinogenesis, and Mutagenesis 15: 81-92. Platzek T, Bochert G, Meister R. (1995)
  • Advancement of methodology for testing ecotoxicity: case studies on quantitative statistical analysis - evaluation of different approaches and example analyses for ecotests with fish and daphnia. F. & E. Berichte, Umweltbundesamt Berlin. Meister R. (1995)
  • Embryotoxicity induced by alkylating agents: 9. Low dose prenatal-toxic risk estimation of ethylmethanesulfonate based on no-observed-adverse-effect-level risk factor approach, dose-response relationships, and molecular dosimetry. Teratog Carcinog Mutagen. 1995; 15(2): 81-92. Platzek T, Bochert G, Meister R. (1995)

1994

  • Biometrical Basics and Principles for Quantitative Risk Assessment Based on Animal Experiments: Models, Benchmarks or NOELs for Reproductive Toxicity Evaluation? Informatik, Biometrie und Epidemiologie in Medizin und Biologie, 25, (4). Meister R. (1994)
  • Probitanalyse und qualitative Dosis-Wirkungsanalysen mit SAS-Beispielen und einem Anhang zu PROC PROBIT. Manuskript, 55 Seiten. Meister R. (1994)

1993

  • Biomathematische Modelle und Analysen für die Risikoabschätzung in der Ökotoxikologie, TFH-Forschungsberichte. Meister R. (1993)
  • Zur Risikoabschätzung in der Ökotoxikologie (Berlin, Kolloquium: Statistische Methoden in der experimentellen Forschung). Meister R. (1993)
  • Embryotoxicity Induced by Alkylating Agents: 7. Low Dose Prenatal-Toxic Risk Estimation Based on NOAL Risk Factor Approach, Dose-Response Relationships, and DNA Adducts using Methylnitrosourea as a Model Compound. Teratogenesis, Carcinogenesis, and Mutagenesis 13: 101-125. Platzek T, Bochert G, Meister R, Neubert D. (1993)

1992

  • ECOLOGIT, A Program to Analyse Quantal-Response Data, Reference Manual. UBA F&E Gutachten. Meister R. (1992)
  • Aspects of concentration response Analysis, in: Risk Assessment of Prenatally-Induced Adverse Health Effects. Ed.: Neubert D, Kavlock RJ, Merker HJ, Klein J, Springer, Berlin Heidelberg New York. Meister R. (1992)
  • Prenatal-Toxic Risk Estimation Based on Dose-Response Relationships and Molecular Dosimetrie, in: Risk Assessment of Prenatally-Induced Adverse Health Effects. Ed.: Neubert D, Kavlock RJ, Merker HJ, Klein J, Springer, Berlin Heidelberg New York. Platzek T, Bochert G, Meister R, Neubert D. (1992)
  • Biometrische Analysen von Konzentrations-Wirkung- Beziehungen und Konzentrations-Zeit-Beziehungen von Altstoffen, Forschungsbericht TFH Berlin FB2. Meister R, Fischer R, Killinger J, Retamal C, Roll A, Rupp-Dahlem M, Schneider P. (1992)

1991

  • Biometrical Analysis of Strain Differences and Litter Effects. A Case Study, in: Lecture Notes in Medical Informatics 43: Statistical Methods in Toxicology, Hothorn L. (ed), Springer, Berlin, Heidelberg, 96-103. Meister R, Chahoud I, Jürgens M, Iversen F, Bochert G. (1991)

1990

  • Safety limits and remaining risk - problems of risk assessment. abstract, Biom. Bull. Meister R. (1990)
  • Biometrische Analyse von Konzentrations- Wirkungsbezeihungen bei neuen Stoffen. UBA F&E Gutachten. Meister R. (1990)

1989

  • Low dose prenatal-toxic risk estimation based on dose-response relationships and DNA adducts using MNU as model compound. Nauny-Schmiedeberg Arch Pharmacol. Platzek T, Bochert G, Fischer B, Meister R. (1989)

1988

  • Gentamycin and Urea concentrations in plasma of non pregnant and pregnant rats and rat fetuses after single and multiple injections, Arch.Toxicol 62: 232-235. Stahlmann R, Chahoud I, Meister R, Düerkop C, Neubert D. (1988)
  • Embryotoxic Effects of Thalidomide Derivatives in the Non-Human Primate Callithrix jacchus: II. Elucidation of the susceptible period and of the variability of embryonic stages. Arch.Toxicol. 61: 180-191. Neubert D, Heger W, Merker H-J, Sames K, Meister R. (1988)
  • Embryotoxicity and DNA Alkylation in Mouse Embryos Following Combined Administration of EMS and MNU. Nauny-Schmiedeberg Arch Pharmacol 337 (Suppl): R30. Platzek T, Bochert G, Rahm U, Pauli B, Meister R. (1988)
  • Embryotoxicity induced by Alkylating Agents:MNU: Correlation of Teratogenic Potency and DNA Alkylation in Mouse Embryos . Part I: The Teratogenic Potency of MNU in Mice. Arch.Toxicol. 62: 411-423. Platzek T, Bochert G, Pauli B, Meister R, Neubert D. (1988)
  • Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus. II. Elucidation of the susceptible period and of the variability of embryonic stages. Arch Toxicol. 1988 Jan; 61(3): 180-91. Neubert D, Heger W, Merker HJ, Sames K, Meister R. (1988)
  • Embryotoxicity induced by alkylating agents: 5. Dose-response relationships of teratogenic effects of methylnitrosourea in mice. Arch Toxicol. 1988; 62(6): 411-23. Platzek T, Bochert G, Pauli B, Meister R, Neubert D. (1988)
  • Gentamicin plasma concentrations in pregnant and non-pregnant rats and fetuses after single and multiple injections. Arch Toxicol. 1988; 62(2-3): 232-5. Stahlmann R, Chahoud I, Meister R, Düerkop C, Neubert D. (1988)

1987

  • Mutagenic and Carcinogenic Potential and Potency of PCDDs and PCDFs, in: Dioxin - eine technische, analytische, ökologische und toxikologische Herausforderung VDI-Bericht 634, VDI-Verlag Düsseldorf 443-486. Neubert D und Meister R. (1987)
  • Dose-response relationships in prenatal toxicity. Congenit. anomalies 27: 275-302. Neubert D, Bochert G, Platzek, T, Chahoud I, Fischer B, Meister R. (1987)
  • Plasma concentrations of acyclovir in pregnant rats. Nauny-Schmiedeberg Arch Pharmacol 335 ( Suppl ): R29. Bochert G, Rahm U, Schwabe R, Meister R. (1987)

1986

  • Principles and problems in assessing prenatal toxicity.Arch. Toxicol 51: 1-25. Neubert D, Chahoud I, Platzek T, Meister R. (1986)
  • Dose-Response Studies Using Methylnitrosourea : Dose-Response Studies Using Methylnitrosourea:  Studies on Mechanisms and Dose-Response Relationships of Prenatal Toxicity. In: Welsch F (ed). Approaches to elucidate mechanisms in teratogenesis Proc. of the 8th CIIT Conf. on Toxicol. April 1986, Hemisphere Publ. Corp. Washington, New York, London pp 59-81. Platzek T, Meister R, Chahoud I, Bochert G, Krowke R, Neubert D. (1986)

1984

  • Antibiotika- und Sulfonamidnachweis mit dem biologischen Hemmstofftest: Auswertung von Hemmstofftests und Beschreibung ihrer Dosis- Wirkungsbeziehung mit Hilfe der Logit-Transformation. Fleischwirtschaft 64, 846-852. Hildebrandt G, Meister R, Dornheim O, Schnüll H und Kusch D. (1984)
  • Ansätze zur Quantilschätzung. Dissertation TU Berlin. Meister R. (1984)

1983

  • Entwicklung von Algorithmen und Programmen zur Analyse pharmakokinetischer Daten Forschungsvorhaben in Zusammenarbeit mit dem Bundesgesundheitsamt. Abschlussbericht. Antes G, Eichhorn E und Meister R. (1983)
  • PHAKIN - ein Dialogprogramm zur Analyse pharmakokinetischer Verlaufskurven, Statistical Software Newsletters, 9 (3). Antes G, Eichhorn E und Meister R. (1983)

1981

  • Ausmaß und Bedeutung der zwischenbetrieblichen Streuung bei einem im Werkvertrag hergestellten Schweinefleisch im eigenen Saft. Fleischwirtschaft 61, 1469-1477. Hildebrandt G, Meister R u.a. (1981)

1980

  • Die gewebliche Zusammensetzung verschiedener in Handel erhältlicher Steaksorten unter besonderer Berücksichtigung des Schweinenacken-Steaks. Fleischwirtschaft 60, 1958-1963. Hildebrandt G und Meister R. (1980)

1979

  • Entwicklung eines modular aufgebauten Programmsystems zur optimalen Erfassung, Speicherung und Auswertung von Daten bei klinischen Arzneimittelprüfugen. 4. Mitteilung: Anwendungsbeispiel. EDV in Medizin und Biologie Band 10, Heft 2. Meister R, Ellmer H, Grünberg U, Hartmann E, Kaufmann J, Lehnert J, Röpke H, Rosenfeld E. (1979)

1978

  • In Vitro and in Vivo Availability of Spirolonactone from Various Oral Preparations. Drug Development and Industrial Pharmacy, 4(4), 389-411. Raptis G, Wendt H, Meister R und Fuchs P. (1978)